文献速递免疫规划

重复接种似乎不会显著削弱老年人流感疫苗的保护效果:中国一项检测阴性病例对照研究

Repeated vaccination does not appear to significantly weaken the protective effect of influenza vaccine in the elderly: A test-negative case-control study in China.
PubMed 文献 · Vaccine · 2024-05-18

该研究利用区域健康信息平台,在宁波2018-19至2021-22四个流感季节,对60岁及以上人群开展检测阴性病例对照研究,按就诊医院和检测日期1:1匹配,纳入1976例流感阳性病例和1976例阴性对照。多因素logistic回归显示,连续两季接种者较仅当季接种者的流感风险未显著升高(调整OR 1.22,95%CI 0.94-1.58);仅上季接种者风险升高(调整OR 1.56,95%CI 1.15-2.10),两季均未接种者风险更高(调整OR 3.39,95%CI 2.80-4.09)。结论认为无论上季接种史如何,接种当季流感疫苗是老年人的最佳选择。

要点

  • 连续两季接种者较仅当季接种者流感风险未显著升高(调整OR 1.22,95%CI 0.94-1.58)。
  • 仅上季接种者流感风险升高(调整OR 1.56,95%CI 1.15-2.10)。
  • 两季均未接种者流感风险更高(调整OR 3.39,95%CI 2.80-4.09)。

核心结论

  • 无论上一季接种史如何,接种当季流感疫苗是老年人的最佳选择,研究支持老年人每年接种流感疫苗的倡议。

研究设计与样本

  • 采用检测阴性病例对照研究,利用区域健康信息平台,在宁波2018-19至2021-22四个流感季节对60岁及以上人群开展。
  • 流感阳性病例与阴性对照按就诊医院和流感检测日期1:1匹配。
  • 共30,630名老年患者接受流感病毒核酸或抗原检测,排除后纳入1976例流感阳性病例和1976例流感阴性对照。
  • 使用倾向评分调整和多因素logistic回归估计风险并处理混杂效应。

主要发现

  • 连续两季接种者较仅当季接种者流感风险未显著升高(调整OR 1.22,95%CI 0.94-1.58)。
  • 仅上季接种者流感风险升高(调整OR 1.56,95%CI 1.15-2.10)。
  • 连续两季均未接种者流感风险进一步升高(调整OR 3.39,95%CI 2.80-4.09)。

临床怎么用

  • 作者结论认为,无论上一季接种史如何,接种当季流感疫苗是老年人的最佳选择,研究支持老年人每年接种流感疫苗的倡议。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of repeated influenza vaccination on vaccine effectiveness has been a topic of debate. Conducting more multinational, multicenter studies in different influenza seasons is crucial for a better understanding of this issue. There is a lack of comprehensive related research reports in China. METHODS: Using the Regional Health Information Platform, we conducted a test-negative case-control study to evaluate the impact of repeated vaccination on the prevention of laboratory-confirmed influenza in individuals aged 60 and above in Ningbo during four influenza seasons from 2018-19 to 2021-22. Influenza-positive cases and negative controls were matched in a 1:1 ratio based on the visiting hospital and the date of influenza testing. Propensity score adjustment and multivariable logistic regression were used to estimate risk and address confounding effects. RESULTS: During the study period, a total of 30,630 elderly patients underwent influenza virus nucleic acid or antigen testing. After exclusions, we included 1976 cases of influenza-positive and 1976 cases of influenza-negative controls. Multivariable logistic regression analysis revealed that individuals receiving the vaccine in two consecutive seasons did not exhibit a significantly increased risk of influenza illness compared to those receiving the vaccine only in the current season (adjusted odds ratio: 1.22, 95% confidence interval: 0.94-1.58). However, the risk of influenza illness was found to be elevated in individuals who received the vaccine only in the previous season (adjusted odds ratio: 1.56, 95% confidence interval: 1.15-2.10) and even further elevated in those who had not received the vaccine in either of the consecutive two seasons (adjusted odds ratio: 3.39, 95% confidence interval: 2.80-4.09). CONCLUSIONS: Regardless of the vaccination history in the previous season, receiving the current season influenza vaccine is the best choice for the elderly population. Our study supports the initiative to vaccinate elderly individuals against influenza annually.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Yang T, Tong F, Tang L, et al. Repeated vaccination does not appear to significantly weaken the protective effect of influenza vaccine in the elderly: A test-negative case-control study in China. Vaccine. 2024. PMID: 38762359. doi:10.1016/j.vaccine.2024.05.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。